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Available online 14 October 2016Background: We recently reported that six alleles from class II genes of the Human Leukocyte Antigen (HLA)
confer protection from Gulf War Illness (GWI) (Georgopoulos et al., 2015). The most signiﬁcant effect is exerted
on Neurological-Cognitive-Mood (NCM), Pain, and Fatigue symptoms, such that higher number of copies of the
protective alleles are associated with lower symptom severity. Here we tested the hypothesis that this effect is
exerted by modulating the strength of neural synchronicity.
Methods: Eighty-one Gulf War veterans (65 with GWI and 16 healthy controls) underwent a magnetoencepha-
lography (MEG) scan to assess the strength of brain synchronicity by computing zero-lag crosscorrelations
(and their Fisher z transforms) between prewhitenedMEG time series. A high-resolution HLA genotyping deter-
mined the number of copies, k, of the 6 protective alleles above in each participant. We tested the hypothesis
above by regressing NCM, Pain and Fatigue symptom severity against the interaction term, k × z (HLA-related
effect), while including z (non-HLA-related effect), gender and age as covariates. The k × z and z terms assessed
HLA- and non-HLA-related effects, respectively, of neural synchronicity on symptom severity. The distributions
of these effects in sensor space were visualized using statistical heatmaps.
Findings: We found signiﬁcant, graded HLA- and non-HLA-related effects: (a) NCM N Pain N Fatigue for HLA-
related effects, (b) NCM N Fatigue N Pain for non-HLA-related effects, and (c) HLA-related N non-HLA-related
effects for all symptoms. These effects had widespread but distinct distributions in sensor space that allowed
the orderly separation of the 6 terms (3 symptom domains × 2 HLA factors) in a multidimensional plot, where
one dimension separated the symptoms and the other the HLA relation.
Interpretation: Theseﬁndings demonstrate the presence of substantial, widespread, distinct and orderlyHLA- and
non-HLA-related neural inﬂuences on NCM, Pain and Fatigue symptom severity in GWI.
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Gulf War Illness (GWI) is a disorder that affects multiple systems
and is manifested by various combinations and severities of at least 6
different kinds of symptoms, including Neurological-Cognitive-Mood
(NCM), pain, fatigue, skin rashes, gastrointestinal, and respiratory
symptoms (Institute of Medicine, 2000, 2006, 2010). Based on the pres-
ence of such symptoms, criteria have been developed to establish the di-
agnosis of GWI (Fukuda et al., 1998; Steele, 2000). The cause (or causes)
of GWI are unknown, as is the pathophysiology of the disorder. Diverse1B), Minneapolis VAHCS, One
.
ss article under the CC BY license (htlines of evidence have implicated threemajor factors as triggers, includ-
ing (i) various vaccinations (Georgopoulos et al., 2015; Israeli, 2012;
Toubi, 2012), (ii) various chemical exposures (Institute of Medicine,
2000; Steele et al., 2015) and (iii) various kinds of stress, and, typically,
combinations thereof, since all GW veterans were vaccinated, exposed
to low doses of nerve gas, and subjected to strenuous basic training.
Beyond speciﬁc effects of each one of these factors (White et al.,
2016), a common denominator shared by all is their effects on the
immune system. These effects are diverse, depending on the factor.
Vaccinations obviously target the immune system by inducing immune
responses to the pathogens, but also to the adjuvants, contained in the
vaccines (Israeli, 2012; Toubi, 2012); chemical exposure to subclinical
levels of sarin have been shown to depress immune function
(Henderson et al., 2001); and stress has since long been identiﬁed astp://creativecommons.org/licenses/by/4.0/).
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Marketona and Glasera, 2008). Recent studies have documented
immune dysfunction in GWI (Whistler et al., 2009), and even identiﬁed
an immunosuppressant (methotrexate) as an optimal possible treat-
ment for GWI (Craddock et al., 2015).
Recently, we focused our research on a different aspect of immune
function, at the intersection of immunity and genetics, namely on the
Human Leukocyte Antigen (HLA) (Georgopoulos et al., 2015). HLA
genes are located in the Major Histocompatibility Complex (MHC) of
chromosome 6 and play a central role in immune recognition (Meuer
et al., 1982). HLA genes mediate all speciﬁc immune responses to
intracellular and extracellular substances (Blum et al., 2013). Given
the variety of factors above affecting immunity to which even
nondeployed GW veterans were exposed, we reasoned that an investi-
gation of the HLA genetic makeup in GW veterans, including healthy
controls and veterans suffering from GWI, might reveal a clue on the
susceptibility of GW veterans to develop GWI following immune
challenges, as those above. Indeed, we identiﬁed 6 Class II HLA alleles
which, when present, conferred protection from GWI. Presence or
absence of those alleles classiﬁed correctly healthy and GWI veterans,
respectively and, depending of the number of copies of alleles present,
conferred graded alleviation in GWI symptom severity (Georgopoulos
et al., 2015). Those alleles were: DRB1*01:01, DRB1*08:11,
DRB1*13:02, DQB1*02:02, DPB*01:01, and DPB1*06:01. Since an indi-
vidual has 2 copies of Class II HLA genes, and since HLA genes are highly
polymorphic, the number of copies, collectively, of the 6 protective
alleles that an individual can have is zero, one or two. We found that
the overall GWI symptom severity decreased linearly and signiﬁcantly
as the number of copies of the 6 protective alleles increased. Of the
various GWI symptom domains, HLA protection affected mostly the
symptom severity of NCM, Pain and Fatigue. Since those symptoms
are mediated through the brain, we sought to investigate the brain
mechanisms involved in this protection. More speciﬁcally, we tested
the hypothesis that this protection is exerted by modulating neural
communication patterns, as assessed by brain's synchronous neural
interactions, namely zero-lag, pairwise crosscorrelations calculated
from prewhitened, 60-s resting-state magnetoencephalographic
(MEG) recordings (Georgopoulos et al., 2007). These correlations have
proved powerful in successfully discriminating various brain diseases
(Georgopoulos et al., 2007), including posttraumatic stress disorder
(PTSD) (Georgopoulos et al., 2010; Engdahl et al., 2010), and in identi-
fying neural correlates of resilience to trauma (James et al., 2013), of
posttraumatic growth (Anders et al., 2015), and of measures of psycho-
pathology (James et al., 2015). More importantly, in a recent study of
MEG patterns in GWI (Engdahl et al., 2016) we found synchronous
crosscorrelations differed signiﬁcantly between controls and GWI
patients and could classify successfully (N93% correctly) control and
GWI participants. These ﬁndings provided the framework for this
study, which investigated more speciﬁcally the relations between
these correlations and speciﬁc GWI symptomatology.
2. Materials and Methods
2.1. Study Participants
We studied a total of 81 veterans, 16 controls (15 men, 1 woman;
age range 43–71 y; 54.9 ± 10.2 y, mean ± SD) and 65 GWI (63 men,
2 women; age range 39–76 y; 50.8 ± 7.9 y). (This is the same group
studied in Georgopoulos et al., 2015, less one GWI participant for
whomwe did not haveMEG scan.) All participants had deployed during
the Gulf War and were free of autoimmune disease, including multiple
sclerosis, lupus, rheumatoid arthritis, psoriasis, Sjögren's syndrome, or
Graves disease. Assignment to control or GWI group was based on
established criteria, as described in Georgopoulos et al. (2015); speciﬁ-
cally, a participant was assigned to the GWI group whenmeeting either
the Centers for Disease Control and Prevention (CDC) criteria (Fukudaet al., 1998) or the Kansas GWI case deﬁnition (Steele, 2000). For that
purpose, participants completed a symptom presence/severity
questionnaire developed for use in Kansas Gulf War veterans (Steele,
2000) that evaluates a range of symptoms associatedwith GWI and per-
mits determination of case status according to either the CDC criteria
(Fukuda et al., 1998) or the Kansas GWI case deﬁnition (Steele, 2000).
The questionnaire asks participants to indicate if they have had a persis-
tent problem over the last 6 months with various symptoms from the
following six domains: fatigue, pain, neurological-cognitive-mood,
skin, respiratory, and gastrointestinal. For each symptom rated as
present, participants are asked to rate the severity of the symptom as
absent, mild, moderate, or severe (scored as 0, 1, 2, or 3, respectively),
and to indicate whether the symptom ﬁrst became problematic before,
during or after deployment to the Gulf. Only symptoms that began dur-
ing or after Gulf War service are counted toward diagnosis. There were
six symptom domains: NCM, Pain, Fatigue, Skin, Gastrointestinal, and
Respiratory (Steele, 2000). Individual symptom severity was reported
in a scale from 0 to 3, as described above. For each participant, an
average score per domain was calculated. In this study, only the scores
for NCM, Pain and Fatigue were used.
2.2. HLA Genotyping
DNA isolation was carried out from 3 ml of whole blood drawn in
EDTA tubes, using a commercially available kit (ArchivePure cat.
2300730) from 5Prime (distributed by Fisher Scientiﬁc or VWR) with
an expected yield of 50–150 μg of DNA. The puriﬁed DNA samples
were sent to Histogenetics (http://www.histogenetics.com/) for high-




Their sequencing DNA templates are produced by locus- and group-
speciﬁc ampliﬁcations that include exon 2 and 3 for Class I (A, B, C)
and exon 2 for Class II (DRB1, DRB3/4/5, DQB1, and DPB1) and reported
as Antigen Recognition Site (ARS) alleles as per ASHI recommendation
(Cano et al., 2007).
2.3. Data Acquisition
As described previously (Georgopoulos et al., 2007, 2010), subjects
lay supinewithin the electromagnetically shielded chamber and ﬁxated
their eyes on a spot ~65 cm in front of them, for 60 s. MEG data were
acquired using a 248-channel axial gradiometer system (Magnes
3600WH, 4-D Neuroimaging, San Diego, CA), band-ﬁltered between
0.1 and 400 Hz, and sampled at 1017.25 Hz. Data with artifacts (e.g.




Standard statistical methods were used to analyze data (analysis of
covariance [ANCOVA], correlation, etc.) (Snedecor and Cochran, 1980)
using, as needed, the IBM-SPSS statistical package (version 24), the
Matlab package (version R2015b), time series analysis programs
written in Python (Mahan et al., 2015), and ad hoc Fortran computer
programs employing the International Mathematics and Statistics
Library (IMSL; Rogue Wave Software, Louisville, CO, USA) statistical
and mathematical libraries.
2.4.2. MEG Data
Single trialMEG data from all sensors underwent prewhitening (Box
and Jenkins, 1976; Priestley, 1971) using a (50,1,3) ARIMA model
(Mahan et al., 2015) to obtain practically white noise innovations (i.e.
residuals). As we have argued previously (Engdahl et al., 2010), the
Table 1
Counts of the 6 HLA protective alleles for the control and GWI groups.
HLA protective allele count Control GWI Total
0 3 46 49
1 10 19 29
2 3 0 3
Total 16 65 81
74 L.M. James et al. / EBioMedicine 13 (2016) 72–79high-frequency sampling of the MEG signal at a resting state (i.e. in the
absence of time-locked strong signals aligned to a speciﬁc event), and its
millisecond-by-millisecond differencing suggest that it originates from
widely distributed, small intensity cortical generators reﬂecting
integrated synaptic activity in small neuronal populations. For each
brain scan, all possible pairwise zero-lag crosscorrelations rij between
the innovations of i and j sensors (N = 30,628, given 248 sensors)
were computed. Since, in this analysis, we were interested in the
strength of neural synchronicity, irrespective of its sign, we took the
absolute value r′ij of rij and computed its Fisher (1958) z-transform to
normalize its distribution:
zij ¼ atanh r0ij
  ð1Þ
2.4.3. Testing for HLA-neural Interactions
Our working hypothesis on how symptom severity may be the
outcome of HLA-related and non-HLA-related effects on brain function
is illustrated in Fig. 1. We tested this hypothesis by performing three
multiple linear regression where the dependent variable was NCM,
Pain, or Fatigue symptom severity and the independent variables in-
cluded a HLA-related variable (coded as an multiplicative interaction
term, kzij, where k is the number of copies of the 6 HLA protective
alleles), a non-HLA-related variable (zij), and age and gender as covari-
ates:
Symptom severity ¼ aþ b kzij
 þ czij þ d Ageð Þ þ e Genderð Þ þ ε^ ð2Þ
where a is a constant, b–e are partial regression coefﬁcients, and ε^ is an
error term. This analysis provided a general assessment of our hypoth-
esis. A more detailed analysis was also performed using the same
regression model above but applied separately to individual sensor
pairs (N = 30,628 pairs from 248 sensors). This provided information
concerning the distribution of HLA-related and non-HLA-related effects
in the brain, as visualized in statistical heatmaps, constructed as follows.
For each iMEG sensor, there are 247zij, corresponding to the remaining
247 j sensors. Therefore, 247 multiple regressions were performed
(Eq. (2)) for each sensor. This analysis gives a t value for each partial
regression coefﬁcient in Eq. (2) (i.e. the ratio of the coefﬁcient over its
standard error). The absolute t value, | t |, is essentially a signal-to-
noise ratio that indicates the degree of conﬁdence in the effect;Fig. 1. Scheme of working hypothesis regarding HLA-related and non-HLA-related effects
on GWI NCM, Pain and Fatigue symptom severity.corresponding probability values are uncorrected for multiple compar-
isons, since they are not used for speciﬁc hypothesis testing. In a
heatmap, the color at a sensor location was varied according the
maximum | t | value of the partial regression coefﬁcient for a speciﬁc
effect (i.e., b and c coefﬁcients in Eq. (2) for a HLA- and non-HLA-related
effects, respectively). Finally, the |t | values were used in a multidimen-
sional scaling (MDS) analysis aimed to visualize in the same plot the
symptomdomain (NCM, Pain, Fatigue) and the HLA-neural dependence
(HLA-related, non-HLA-related), as follows. Each heatmap consisted of
248 |t | values, oneperMEG sensor. A 6×6proximity (similarity)matrix
was constructed consisting of all 15 pairwise coefﬁcients of determina-
tion (r2) between the 6 Symptom × HLA-effect combinations. This
matrix was then fed as input to the IBM-SPSS procedure PROSCAL
using a non-metric (ordinal) MDS model which yielded a 2-D plot of
the 6 combinations and associated goodness of ﬁt statistics.
3. Results
The two groups in this study (control and GWI) differed substantial-
ly in their composition regarding the counts of 6 HLA protective alleles
(Table 1): controls had higher counts (including 3 participants with 2
alleles), whereas GWI participants had lower counts, without a single
participant with 2 alleles. This differential count distribution was highly
statistically signiﬁcant (Chi-square test, χ[2]2 =21.9,P=0.000018 ).
3.1. General Effects
The dependence of NCM, Pain and Fatigue severity on the number of
copies of the 6 protectiveHLA alleles is shown in Figs. 2–4. The similarity
of the ﬁtted lines stems from the fact that symptom severity was
signiﬁcantly correlated (Pb0.001) among the three domains
(r=0.604,0.698,0.567 for NCM vs. Pain, NCM vs. Fatigue, and Pain vs.
Fatigue, respectively), a typical feature of GWI. With respect to the
brain, there was an overall strong and highly signiﬁcant effect of theFig. 2. NCM symptom severity (±SEM) is plotted against the number of copies of the 6
protective HLA alleles. N refers to the number of participants. R2=0.221,P=0.00065.
Fig. 3. Pain severity (±SEM) is plotted against the number of copies of the 6 protective
HLA alleles. N refers to the number of participants. R2=0.174,P=0.0001.
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(standardized partial regression coefﬁcient |β |=0.274 ,0.232 ,
and 0.200 for NCM, Pain and Fatigue, respectively, P b 0.001 for all
three coefﬁcients). Therewas also aweaker effect of the non-HLA-related
term zij: (|β |=0.156,0.136,and 0.109 for NCM, Pain, and Fatigue,
respectively, P b 0.001 for all three coefﬁcients). There was no signiﬁcant
collinearity between kzij and zij (tolerance for both terms = 0.7 in all
regression analyses).
3.2. Regional Distribution of Effects
The results of the analyses per sensor are illustrated in the heatmaps
of Figs. 5–7 and summarized in Fig. 8. It can be seen that, in general,
HLA-related effects were stronger than non-HLA effects (left vs. right
panels in Figs. 5–7, and ﬁlled vs. open circles in Fig. 8). Interestingly,
all HLA-related effects spared the right anterior temporal lobe. More
speciﬁcally, the following can be seen. (a) For NCM (Fig. 5), the HLA-
effects were strong and widespread, whereas the non-HLA-related
effectsweremostly focused and centered on the right anterior temporal
lobe, medial prefrontal cortex, posterior parietal and occipital cortex.Fig. 4. Fatigue severity (±SEM) is plotted against the number of copies of the 6 protective
HLA alleles. N refers to the number of participants. R2=0.142,P=0.001.(b) For Pain (Fig. 6), the HLA-related effects are stronger than the
non-HLA-related effects but are similarly distributed in central parietal
areas. Finally, for Fatigue (Fig. 7), although HLA-related effects are
stronger on the average (Fig. 8), the non-HLA related effects are
stronger in speciﬁc areas. Both HLA- and non-HLA-related effects in-
volve medial and left prefrontal areas, non-HLA-related effects involve,
in addition, left temporal cortex, right posterior parietal cortex and
right cerebellum.
3.3. Multidimensional Scaling Analysis
The results of the MDS analysis are shown in Fig. 9. The proximity
(similarity) matrix that was used as the input to this analysis is
given in Table 2. It consists of the correlation coefﬁcients between the
248 t-values of each heatmap (Figs. 5–7), It can be seen that MDS iden-
tiﬁed successfully the 2 dimensions of the data, namely the symptom
domain (Dimension 1) and the HLA relation (Dimension 2). The ﬁt
was excellent (normalized raw stress = 0.0083, Dispersion Accounted
For = 0.99).
4. Discussion
Here we evaluated the interactive effects of six Class II HLA alleles
and neural synchrony on NCM, Pain and Fatigue symptom severity in
Gulf War veterans. Our results demonstrated a highly signiﬁcant effect
of the HLA × neural synchrony interaction, particularly on NCM scores
which revealed widespread effects involving much of the cortex and
the cerebellum. A limitation of the study concerns the relatively small
sample size (N = 81 participants); a larger study is needed to further
validate these ﬁndings.
4.1. NCM, Pain and Fatigue Symptom Severity is Associated with HLA-related
Modulation of Neural Synchrony
We previously demonstrated protective effects of certain Class II
HLA alleles on several GWI symptom domains, the most prominent of
which included NCM, Pain and Fatigue (Georgopoulos et al., 2015).
Speciﬁcally, symptom severity decreased with the number of copies
(zero, one, or two) of six HLA alleles that successfully discriminated
GWI from control participants. The present study demonstrated that
protection was conferred via genetic modulation of neural communica-
tion. Synchronous neural activity is central to several cognitive
functions including attention, memory, and sensory-motor integration.
Cognitively healthy individuals display remarkably similar patterns of
neural synchronicity (Langheim, 2006), whereas alterations in neural
synchrony have been associated with several neuropsychiatric disor-
ders (Engdahl et al., 2010; Georgopoulos et al., 2007, 2010; James et
al., 2013, 2015; Uhlhaas and Singer, 2006). We have recently demon-
strated that GWI is also associatedwith aberrant synchronicity affecting
cortical areas and the cerebellum (Engdahl et al., 2016). Our working
hypothesis (Fig. 4) is that, when exposed to certain triggers (e.g.,
vaccines, chemical exposures, and stress), genetically (HLA) vulnerable
veterans exhibit widespread synchronicity anomalies that contribute to
the diverse problems included under the NCM, Pain and Fatigue
domains, and, conversely, the presence of protective HLA alleles
would prevent these anomalies. Our analyses teased out such HLA-re-
lated effects from non-HLA-related effects. These two kinds of effects
differed according to the symptom domain. The symptom of Pain
(Fig. 6) was the simplest one: the patterns of regional distribution of
the effects were very similar (areas a, b, c in left and right panels of
Fig. 6) but stronger and a bit more widespread (areas d and e in the
left panel of Fig. 6) in the HLA-related than in the non-HLA-related
case. These effects encompassed parietal areas (tentatively, ﬁrst [area
c in Fig. 6] and second somatosensory cortex [area b]), known to be
involved in pain (Alonso et al., 2010; Mazzola et al., 2012). The prepon-
derance of left hemispheric involvement in this study (Fig. 6) is difﬁcult
Fig. 5.Heatmaps ofHLA-related andnon-HLA-related effects onNCM severity. Color scale indicatesmaximumabsolute value of the t-statistic (or its corresponding uncorrectedprobability
value) for a given sensor location. (See text for details.) Approximate areas of large effects are demarcated by circles. a, anterior temporal lobe; b, medial frontal cortex; c–e, posterior
parietal and occipital cortex.
76 L.M. James et al. / EBioMedicine 13 (2016) 72–79to explain and remains to be further investigated. It is possible that this
may reﬂect an engagement of language/verbalization in coping with
chronic pain.
Concerning Fatigue (Fig. 7), the interplay between HLA- and non-
HLA-related effects was reversed, in that effects in speciﬁc common
areas involved (medial frontal and left prefrontal, areas labeled a and
b, respectively, in the left and right panels of Fig. 7) were stronger in
the non-HLA-related than the HLA-related case. Moreover, there were
three additional foci in the non-HLA-related effects, most notably in
the left temporal cortex. However, there were, overall, more wide-
spread effects in the HLA-related case, leading to a stronger average
effect (Fig. 8).
Finally, the NCM case (Fig. 5) demonstrates a strong and pervasive
HLA-related effect, in contrast to weaker, localized non-HLA-effects
involving speciﬁc areas, most notably the anterior right temporal lobe
(labeled a in the right panel of Fig. 5), medial prefrontal cortex (area
b), posterior parietal areas bilaterally (areas c, d), and right occipital
cortex (area e). This distribution is very similar to that observed in un-
complicated PTSD (see Fig. 2 in Engdahl et al., 2010) and reﬂects deﬁcitsFig. 6. Heatmaps of HLA-related and non-HLA-related effects on Pain severity. Color scale ind
details.) All areas in both plots are in parietal cortex.in decisionmaking, attention andmemory, to name but a few functions
subserved by the areas above. Speciﬁcally, the involvement of areas a, c,
d and e in the right panel of Fig. 5 are clearly overlapping with those in
Fig. 2 of Engdahl et al. (2010). It is noteworthy that all non-HLA-related
effects (right panel of Fig. 5)were present and stronger in theHLA-relat-
ed heatmap (left panel of Fig. 5) except for the effect involving the right
anterior temporal lobe which was practically absent in the HLA-related
case.
4.2. Multidimensional Scaling
The heatmaps of Figs. 5–7 share similarities and differences
reﬂectingHLA- andnon-HLA-related associations of brain synchronicity
to symptom severity. However, they do not, at ﬁrst glance, convey,
collectively, any order or arrangement regarding shared aspects of
their origin, namely the symptom domain or HLA relation to which
they belong. We sought to derive such an arrangement by applying
MDS, a venerable method for uncovering basic dimensions in a multidi-
mensional dataset (Shepard, 1980, 1988). TheMDS is awell-establishedicates maximum absolute value of the t-statistic for a given sensor location. (See text for
Fig. 7. Heatmaps of HLA-related and non-HLA-related effects on Fatigue severity. Color scale indicates maximum absolute value of the t-statistic for a given sensor location. (See text for
details.) a, medial frontal cortex; b, prefrontal cortex; c, temporal cortex; d, posterior parietal cortex; e, cerebellum.
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proved valuable in psychological (Shepard, 1980, 1988; Whang et al.,
1999), psychiatric (Stephane et al., 2003), and neuroscientiﬁc applica-
tions (Leuthold et al., 2013; Tagaris et al., 1998; Tzagarakis et al., 2009;
Young, 1992; Young and Yamane, 1992; Young et al., 1995). It typically
reveals underlying dimensions along which variables are ordered, di-
mensions that may be hidden when embedded in a multidimensional
space. Our MDS analysis of the associations among the six heatmaps
(Figs. 5–7) revealed a striking arrangement (Fig. 9) which cleanly
ordered the symptom domain and HLA relation in two dimensions
with high goodness of ﬁt. This result further validates the statistical
analyses that led to the construction of the heat maps and underscores
the internal consistency of the derived associations.
4.3. HLA-related Brain Mechanisms in GWI
The nature of the mechanisms by which HLA effects are exerted are
unknown. Given the role of HLA in immune function, and the fact that
our 6 protective alleles are all from HLA class II genes (Georgopoulos
et al., 2015), it is reasonable to suppose that the HLA-conferred protec-
tion in GWI is mediated through speciﬁc, adaptive immunity mecha-
nisms, manifested in successful elimination of pathogens. We assumeFig. 8.Mean (±95% conﬁdence intervals) heatmap |t| value, from maps in Figs. 5–7.that our alleles were instrumental in that process, since their absence
is associated with the presence of GWI and high severity of GWI symp-
toms. It is reasonable, then, to suppose that this is due to pathogens that
could not be eliminated in the absence of those alleles. There are two
obvious mechanisms for this effect. First, if pathogens are not eliminat-
ed, they are allowed to persist in the body, even in a relatively
inactivated form, and produce some harm. And second, their persis-
tence may trigger the production of autoantibodies, if the pathogens
happen to share common antigenic structure with body proteins, and
this may lead to autoimmunity. The most obvious potential pathogens
for Gulf War veterans include the vaccines administered (multiply in
some veterans, see Institute of Medicine, 2000) and their adjuvants
(Asa et al., 2000). The potential adverse role of the various vaccinations
is described in detail in the report by the Institute of Medicine (2000),
and speciﬁc mention is made of HLA in that context. At that time,
research on HLA's role in disease was focused on discovering HLA
genes associated with it, an ongoing, perennial focus in the effort to un-
derstand disease pathogenesis till now. However, the fundamental and
overall role of HLA, and associated T lymphocytemechanisms, is basical-
ly protective, namely to eliminate offending pathogens. If that is lacking
genetically, as, for example in bare lymphocyte syndrome (DeSandro etFig. 9.MDS object plot of the six Symptom × HLA combinations. (See text for detail.)
Table 2
Correlation matrix between the six heatmaps of Figs. 5–7.
HLA-NCM HLA-Pain HLA-Fatigue nonHLA-NCM nonHLA-Pain nonHLA-Fatigue
HLA-NCM 1.000
HLA-Pain 0.587 1.000
HLA_Fatigue 0.613 0.357 1.000
nonHLA-NCM 0.511 0.313 0.311 1.000
nonHLA-Pain 0.291 0.447 0.157 0.281 1.000
nonHLA-Fatigue 0.243 0.061 0.352 0.380 0.169 1.000
78 L.M. James et al. / EBioMedicine 13 (2016) 72–79al., 1999; Reith and Mach, 2001) or compromised (e.g. by administra-
tion of immunosuppressive medications, infection by human immuno-
deﬁciency virus, etc.), increased risk to infections ensues. In GWI, an
increased risk for various infections has been reported (Institute of
Medicine, 2010; Nicolson et al., 2000, 2002), suggesting a reduced
ability to deal effectively with infections, probably due to immune
dysfunction. Now, there is a link between chronic infections and the
development of autoimmune disorders (Sherbet, 2009). In addition, a
possible, direct connection of GWI to autoimmunity has been suggested
(Asa et al., 2000; Israeli, 2012, Georgopoulos et al., 2015) and supported
by the emergence of methotrexate, an immunosuppressive drug, as a
possible treatment for GWI (Craddock et al., 2015).
This connection of GWI to autoimmunity is probably the best expla-
nation of the HLA-related neural effects found in this study. Speciﬁcally,
we hypothesize that, in the absence of HLA protection, brain autoimmu-
nity develops in GWI, i.e. antibodies against antigens in the brain,
resulting in cellular abnormalities, abnormal neural communication,
and symptomatology – all graded according to the level of protection
present (i.e. 0, 1 or 2 protective allele copies). At face value, neural
communication is commonly assessed by calculating the correlation co-
efﬁcient, and it is the modulation of the correlation between MEG time
series thatwe have identiﬁed here as a signiﬁcant factor associatedwith
GWI symptomatology. Now, the correlation coefﬁcient between two
variables is calculated as the ratio of their covariance over the product
of the square root of their variances. Therefore, a change in correlation
can stem from a change in covariance, the variances, or both. These pos-
sibilities have different implications; for example, a change in covari-
ance would point to an alteration in network functional interactions,
whereas a change in variance would indicate an alteration in local neu-
ral processing. Both mechanisms would make the correlation stronger
but for different reasons. Although the speciﬁc cellular/biochemical
mechanisms for such changes in correlation are unknown, they are like-
ly to share similar mechanisms that underlie brain dysfunction in other
autoimmune or inﬂammatory brain disorders (Selmi et al., 2016),
including neuropsychiatric lupus (Belmont et al., 1996; Menon et al.,
1999; Omdal et al., 2005), rheumatoid arthritis (Shin et al., 2012),
Sjögren's syndrome (Tezcan et al., 2016), and psoriasis (Gisondi et al.,
2014). A special case is autoimmune encephalitis where the investiga-
tion of cellular autoimmune mechanisms has progressed appreciably
(Armangue et al., 2015; Boronat et al., 2013; Clemente-Casares et al.,
2016; Dalmau and Rosenfeld, 2008, 2014; Linnoila et al., 2014).
4.4. Non-HLA-related Brain Mechanism in GWI
Our analyses distinguished HLA-related from non-HLA-related asso-
ciations between GWI NCM, Pain and Fatigue symptom severity and
neural synchronicity. The non-HLA-related effects for NCM and Pain
are interpretable based on prior knowledge concerning the neural
mechanisms underlying such symptoms. For example, the pattern in
the non-HLA-related heatmap for NCM (right panel of Fig. 5) is very
similar to that we reported for uncomplicated PTSD (Fig. 2 in Engdahl
et al., 2010). This pattern is in clear contrast to the HLA-related effects
(left panel in Fig. 5) which are stronger and much more widespread
encompassingmany areas but, conspicuously, sparing the right anterior
temporal lobe, a strong focus of the non-HLA-related effect. This
suggests that non-HLA-related effects reﬂect other factors, includingpossibly other genes and environmental factors, the nature of which re-
mains to be determined. For instance, Steele et al. (2015) found elevated
risk for GWI in veterans who reported warzone use of pyridostigmine
bromide, an acetylcholinesterase inhibitor, and had a less common
variant of the butyrylcholinesterase enzyme relative to veterans with
other genotypes. The inﬂuence of other genes in promoting protection
or susceptibility to GWI symptoms remains to be determined.
Concerning Pain (Fig. 6), non-HLA-related effects were as expected
from the literature, namely encompassing parietal areas. This pattern
was enhanced and extended in the HLA-related case, which thus
added further sensitization but did not alter the basic pattern. In con-
trast, in the Fatigue case (Fig. 7), the distinct pattern observed for non-
HLA-related effects (right panel in Fig. 7)was blurred in the HLA-related
heatmap (left panel in Fig. 7) and substituted by widespread, relatively
homogeneous effects.
5. Concluding Remarks
These ﬁndings underscore the diversity of brainmechanisms under-
lying GWI symptom severity and the complex interplay of HLA-related
and non-HLA-related factors. Of course, the overall symptom severity
reﬂects both of those factors but the separation in brain patterns we
have documented opens the possibility of tailoring targeted therapeutic
interventions at multiple, different levels, namely traditional ap-
proaches aimed to alleviate symptoms but also interventions targeting
immune dysfunction aimed to correct cellular/biochemical abnormali-
ties giving rise to the symptoms.
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